Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 824 of 1,261

  1. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  2. US 8685411

    Rotavirus antigens

    The United States of America as represented by the Dept. of Health and Human Services (DHHS) · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  3. US 8686010

    Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  4. US 8686041

    Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

    Northwestern University · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  5. US 8685932

    Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

    OPTION PHARMACEUTICALS, LLC · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  6. US 8685926

    Compositions and method for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  7. US 8685404

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  8. US 8686184

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  9. US 8686143

    Compounds useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  10. US 8686157

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  11. US 8686045

    Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  12. US 8686016

    Schweinfurthins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  13. US 8685973

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  14. US 8685936

    Sphingosine kinase inhibitor prodrugs

    Apogee Biotechnology Corporation · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  15. US 8686012

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  16. US 8685979

    Oligomer-diarylpiperazine conjugates

    Nektar Therapeutics · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  17. US 8679476

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  18. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  19. US 8680066

    Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject

    The United States of America as represented by the Development of Veterans Affairs · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  20. US 8680065

    Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  21. US 8680084

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  22. US 8680056

    Antiproliferative factor and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  23. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  24. US 8680021

    Zinc finger proteins for DNA binding and gene regulation in plants

    Sangamo Biosciences, Inc. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.